Efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria in Papua New Guinea-Reference-Cited by-同舟云学术

Efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria in Papua New Guinea

Published:2018-10-05 Issue:1 Volume:17 Page:
ISSN:1475-2875
Container-title:Malaria Journal
language:en
Short-container-title:Malar J

Author:

Tavul Livingstone^ORCID,Hetzel Manuel W.,Teliki Albina,Walsh Dorish,Kiniboro Benson,Rare Lawrence,Pulford Justin,Siba Peter M.,Karl Stephan,Makita Leo,Robinson Leanne,Kattenberg Johanna H.,Laman Moses,Oswyn Gilchrist,Mueller Ivo

Funder

Global Fund to Fight AIDS, Tuberculosis and Malaria

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/content/pdf/10.1186/s12936-018-2494-z.pdf

Reference26 articles.

1. WHO. World malaria report 2017. Geneva: World Health Organization; 2017.

2. WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015.

3. Guerin PJ, Bates SJ, Sibley CH. Global resistance surveillance: ensuring antimalarial efficacy in the future. Curr Opin Infect Dis. 2009;22:593–600.

4. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455–67.

5. PNG Department of Health. National malaria treatment policy. PNG: Port Moresby; 2009.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining malaria parasite population subdivisions, transmission dynamics and infection origins using SNP barcodes;2023-09-04

2. Effectiveness of dihydroartemisinin-piperaquine after 10 years as treatment for vivax malaria in Indonesia;The Journal of Infection in Developing Countries;2023-05-31

3. A campaign of mass drug administration with artemisinin-piperaquine to antimalaria in Trobriand Islands;Preventive Medicine Reports;2023-04

4. Artemisinin promotes apoptosis of spinal tuberculosis macrophages by inhibiting NF-κB;Materials Express;2023-02-01

5. Antimalarials for children with Plasmodium vivax infection: Current status, challenges, and research priorities;Parasitology International;2022-04